173 related articles for article (PubMed ID: 11085938)
1. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.
Shi Y; Zou M; Farid NR; Paterson MC
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):443-8. PubMed ID: 11085938
[TBL] [Abstract][Full Text] [Related]
2. Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit.
Golebiowski F; Szulc A; Szutowicz A; Pawelczyk T
Arch Biochem Biophys; 2004 Aug; 428(2):160-4. PubMed ID: 15246872
[TBL] [Abstract][Full Text] [Related]
3. Association of activating transcription factor 2 (ATF2) with the ubiquitin-conjugating enzyme hUBC9. Implication of the ubiquitin/proteasome pathway in regulation of ATF2 in T cells.
Firestein R; Feuerstein N
J Biol Chem; 1998 Mar; 273(10):5892-902. PubMed ID: 9488727
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase interacts with a novel human ubiquitin conjugating enzyme: hUbc9.
Masson M; Menissier-de Murcia J; Mattei MG; de Murcia G; Niedergang CP
Gene; 1997 May; 190(2):287-96. PubMed ID: 9197546
[TBL] [Abstract][Full Text] [Related]
5. Expression and simple, one-step purification of fragile histidine triad (Fhit) tumor suppressor mutant forms in Escherichia coli and their interaction with protoporphyrin IX.
Zawacka-Pankau J; Podhajska AJ
Biotechnol Lett; 2007 Jun; 29(6):877-83. PubMed ID: 17310323
[TBL] [Abstract][Full Text] [Related]
6. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract][Full Text] [Related]
7. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration].
Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY
Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436
[TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor protein Fhit. A novel interaction with tubulin.
Chaudhuri AR; Khan IA; Prasad V; Robinson AK; Ludueña RF; Barnes LD
J Biol Chem; 1999 Aug; 274(34):24378-82. PubMed ID: 10446217
[TBL] [Abstract][Full Text] [Related]
9. [FHIT--tumor suppressor protein involved in induction of apoptosis and cell cycle regulation].
Pecherzewska R; Nawrot B
Postepy Biochem; 2009; 55(1):66-75. PubMed ID: 19514467
[TBL] [Abstract][Full Text] [Related]
10. Selective monitoring of the enzymatic activity of the tumor suppressor Fhit.
Hacker SM; Mortensen F; Scheffner M; Marx A
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10247-50. PubMed ID: 25098403
[TBL] [Abstract][Full Text] [Related]
11. Implication of mitochondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy.
Askari MD; Vo-Dinh T
Biopolymers; 2004 Mar; 73(4):510-23. PubMed ID: 14991669
[TBL] [Abstract][Full Text] [Related]
12. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines.
Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505
[TBL] [Abstract][Full Text] [Related]
13. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
[TBL] [Abstract][Full Text] [Related]
14. Replacement of Fhit in cancer cells suppresses tumorigenicity.
Siprashvili Z; Sozzi G; Barnes LD; McCue P; Robinson AK; Eryomin V; Sard L; Tagliabue E; Greco A; Fusetti L; Schwartz G; Pierotti MA; Croce CM; Huebner K
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13771-6. PubMed ID: 9391102
[TBL] [Abstract][Full Text] [Related]
15. Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9.
Xu W; Gong L; Haddad MM; Bischof O; Campisi J; Yeh ET; Medrano EE
Exp Cell Res; 2000 Mar; 255(2):135-43. PubMed ID: 10694430
[TBL] [Abstract][Full Text] [Related]
16. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.
Barnes LD; Garrison PN; Siprashvili Z; Guranowski A; Robinson AK; Ingram SW; Croce CM; Ohta M; Huebner K
Biochemistry; 1996 Sep; 35(36):11529-35. PubMed ID: 8794732
[TBL] [Abstract][Full Text] [Related]
17. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.
Ishii H; Dumon KR; Vecchione A; Trapasso F; Mimori K; Alder H; Mori M; Sozzi G; Baffa R; Huebner K; Croce CM
Cancer Res; 2001 Feb; 61(4):1578-84. PubMed ID: 11245468
[TBL] [Abstract][Full Text] [Related]
18. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
[TBL] [Abstract][Full Text] [Related]
19. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
[TBL] [Abstract][Full Text] [Related]
20. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.
Wistuba II; Ashfaq R; Maitra A; Alvarez H; Riquelme E; Gazdar AF
Am J Pathol; 2002 Jun; 160(6):2073-9. PubMed ID: 12057912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
